Clin2
NCT06261450Possibly a fitNot yet recruiting

CBD and brain function study for fragile X syndrome

Fragile X Syndrome

Treatments studied

Part of Brain & nervous system, Genetic & congenital clinical trials.

This study tests whether a daily dose of CBD (a cannabis compound) can change brain activity in people with Fragile X syndrome. It also includes a healthy control group to compare results.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
7 years to 55 years
Study type
Interventional

Who can take part

  • You or your child must be between 7 and 55 years old with a confirmed diagnosis of Fragile X syndrome.
  • IQ must be less than 70.
  • A score above 20 on a standard behavior checklist (ABC-C) is needed.
  • If you take any psychiatric medications, you must be on a stable dose for at least 3 months and take no more than 2.
  • You must weigh at least 60 kg (about 132 lbs) and have no history of liver problems.
  • You cannot have any metal in your head or body that would interfere with MRI or TMS brain scans.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06261502Recruiting· Phase 2
CBD for Anxiety in Fragile X Syndrome

This trial tests if cannabidiol (CBD) can help with anxiety and improve brain function in people with Fragile X syndrome. Participants will receive CBD or a placebo, and may have brain scans (MRI) or magnetic stimulation (TMS) to see how it works.

Sherbrooke, Quebec
NCT07209462Recruiting· Phase 2
MRM-3379 for Fragile X Syndrome in males

This trial tests an investigational medicine called MRM-3379 in males with Fragile X syndrome. It looks at how the medicine affects thinking and behavior over time.

Phoenix, Arizona
NCT07654114Recruiting· Phase 2
Testing CTH120 for men with Fragile X syndrome

This trial tests a new medicine called CTH120 to see if it is safe and helpful for adult men with Fragile X syndrome. You may be able to join if you meet certain health and age requirements.

Barcelona, Barcelona
NCT06560242Recruiting
Tracking early sound perception in Fragile X syndrome

This study uses safe brain monitoring (fNIRS and EEG) to see how infants with Fragile X syndrome process sounds compared to other infants. The goal is to find early signs of hearing or perception issues.

Cincinnati, Ohio
NCT06088589Recruiting
Speech-in-noise in autism and fragile x

This study measures how well people with autism or fragile X syndrome perceive speech in noisy settings, compared to typically developing individuals. It uses EEG to understand brain activity during listening tasks.

Cincinnati, Ohio
NCT06227780Recruiting
Sound therapy for thinking and sensory issues in kids with developmental disorders

This trial tests whether special sound patterns played through headphones can help improve thinking and reduce sensitivity to noise in children with Fragile X syndrome or autism. The study uses a short daily listening program over several weeks to see if it makes a difference.

Cincinnati, Ohio

Hear when a new Fragile X Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.